119 related articles for article (PubMed ID: 20064727)
1. Genetic verification of Bordetella pertussis seed strains used for production of Japanese acellular pertussis vaccines.
Kamachi K; Fukuda T; Han HJ; Toyoizumi-Ajisaka H; Mochida K; Konda T; Horiuchi Y; Arakawa Y;
Biologicals; 2010 Mar; 38(2):290-3. PubMed ID: 20064727
[TBL] [Abstract][Full Text] [Related]
2. Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis.
Chan WF; Maharjan RP; Reeves PR; Sintchenko V; Gilbert GL; Lan R
J Microbiol Methods; 2009 Jun; 77(3):326-9. PubMed ID: 19341769
[TBL] [Abstract][Full Text] [Related]
3. Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan.
Han HJ; Kamachi K; Okada K; Toyoizumi-Ajisaka H; Sasaki Y; Arakawa Y
Vaccine; 2008 Mar; 26(12):1530-4. PubMed ID: 18291563
[TBL] [Abstract][Full Text] [Related]
4. Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.
Kallonen T; Gröndahl-Yli-Hannuksela K; Elomaa A; Lutyńska A; Fry NK; Mertsola J; He Q
Infect Genet Evol; 2011 Dec; 11(8):2034-42. PubMed ID: 21964035
[TBL] [Abstract][Full Text] [Related]
5. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomics of whole-cell pertussis vaccine strains from India.
Alai S; Ghattargi VC; Gautam M; Patel K; Pawar SP; Dhotre DP; Shaligram U; Gairola S
BMC Genomics; 2020 May; 21(1):345. PubMed ID: 32381023
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines.
Guiso N; Boursaux-Eude C; Weber C; Hausman SZ; Sato H; Iwaki M; Kamachi K; Konda T; Burns DL
Vaccine; 2001 Apr; 19(23-24):3248-52. PubMed ID: 11312021
[TBL] [Abstract][Full Text] [Related]
8. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
Sato Y; Sato H
Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530
[TBL] [Abstract][Full Text] [Related]
9. [Genetic variability of Bordetella pertussis strains. Part I. Current knowledge].
Gzyl A; Augustynowicz E; Gniadek G; Slusarczyk J
Przegl Epidemiol; 2003; 57(1):181-92. PubMed ID: 12926327
[TBL] [Abstract][Full Text] [Related]
10. Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines.
Zomer A; Otsuka N; Hiramatsu Y; Kamachi K; Nishimura N; Ozaki T; Poolman J; Geurtsen J
Microb Genom; 2018 May; 4(5):. PubMed ID: 29771235
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of clinical and vaccine strains of Bordetella pertussis by Pulsed-Field Gel Electrophoresis (PFGE), Multi Locus Sequence Typing (MLST) and serotyping.
Bahmanjeh A; Noofeli M; Khaki P; Hassanzadeh SM
Comp Immunol Microbiol Infect Dis; 2019 Jun; 64():168-175. PubMed ID: 31174694
[TBL] [Abstract][Full Text] [Related]
12. Bordetella pertussis vaccine strains and circulating isolates in Serbia.
Dakic G; Kallonen T; Elomaa A; Pljesa T; Vignjevic-Krastavcevic M; He Q
Vaccine; 2010 Feb; 28(5):1188-92. PubMed ID: 19945417
[TBL] [Abstract][Full Text] [Related]
13. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.
Zawadka M; Polak M; Rabczenko D; Mosiej E; Augustynowicz E; Lutyńska A
Vaccine; 2011 Jul; 29(33):5488-94. PubMed ID: 21641954
[TBL] [Abstract][Full Text] [Related]
15. [Genetic variability of Bordetella pertussis strains. Part II. Perspectives].
Gzyl A; Augustynowicz E; Gniadek G; Slusarczyk J
Przegl Epidemiol; 2003; 57(1):193-200. PubMed ID: 12926328
[TBL] [Abstract][Full Text] [Related]
16. Outer membrane vesicles as acellular vaccine against pertussis.
Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
[TBL] [Abstract][Full Text] [Related]
17. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK.
Packard ER; Parton R; Coote JG; Fry NK
J Med Microbiol; 2004 May; 53(Pt 5):355-365. PubMed ID: 15096543
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
[TBL] [Abstract][Full Text] [Related]
19. Real-time polymerase chain reaction detection of Bordetella pertussis DNA in acellular pertussis vaccines.
Tatti KM; Slade B; Patel M; Messonnier N; Jackson T; Kirkland KB; Talbot EA; Tondella ML
Pediatr Infect Dis J; 2008 Jan; 27(1):73-4. PubMed ID: 18162945
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains.
Heikkinen E; Kallonen T; Saarinen L; Sara R; King AJ; Mooi FR; Soini JT; Mertsola J; He Q
PLoS One; 2007 Sep; 2(9):e904. PubMed ID: 17878939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
